All manufacturing process stages, from the synthesis of incoming substances to ready drugs production, are carried out at one single facility.
Today, Nearmedic Pharma factory produces KAGOCEL antiviral drug. New industrial premises intended for the production of reagents for genetic person and filiation identification is under construction. Foundation of a scientific and production complex is planned at the Obninsk site, where research and development of technologies for synthesis and preclinical trials of pharma substances will be performed.
The factory has the RF Ministry of Industry and Trade license No. 00166 LS «For pharmaceuticals production», and a certificate of compliance with standards for quality management systems ISO 9001:2015 issued by ZES International a.s.
Nearmedic Pharma conforms to requirements of Regulations for proper production practices No. GMP-0101-000148/17.
In 2016, Nearmedic Pharma factory won the Event of the Year. Russia 2015 contest in nomination «Main project in Russia’s pharmaceutical industry».